In the past decade, the beta subunit of ATPase has been shown to be ectopicallyexpressed on the outer surface of both normal and tumor cells [23, 27–29] and has been identified as a potential therapeutic target in NSCLC[30] and malignant paragangliomas[31]. This evidence concerns the gene DNAH8 and Malignant Paraganglioma.